OtherBehavioral Pharmacology
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J Rahn, Alexander M. Zvonok, Ganesh A. Thakur, Atmaram D. Khanolkar, Alexandros Makriyannis and Andrea G Hohmann
Journal of Pharmacology and Experimental Therapeutics July 29, 2008, DOI: https://doi.org/10.1124/jpet.108.141994
Elizabeth J Rahn
Alexander M. Zvonok
Ganesh A. Thakur
Atmaram D. Khanolkar
Alexandros Makriyannis
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherBehavioral Pharmacology
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J Rahn, Alexander M. Zvonok, Ganesh A. Thakur, Atmaram D. Khanolkar, Alexandros Makriyannis and Andrea G Hohmann
Journal of Pharmacology and Experimental Therapeutics July 29, 2008, DOI: https://doi.org/10.1124/jpet.108.141994
OtherBehavioral Pharmacology
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J Rahn, Alexander M. Zvonok, Ganesh A. Thakur, Atmaram D. Khanolkar, Alexandros Makriyannis and Andrea G Hohmann
Journal of Pharmacology and Experimental Therapeutics July 29, 2008, DOI: https://doi.org/10.1124/jpet.108.141994
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement